Literature DB >> 28509127

Membranous glomerulonephropathy in a patient with bullous pemphigoid.

Misa Ikeda1, Hirokazu Honda2,3, Naoto Kobayashi1, Shoko Onuma1, Kei Matsumoto1, Tadao Akizawa1, Yutaka Yamaguchi4, Takanori Shibata1.   

Abstract

Bullous pemphigoid (BP) is a common autoimmune blistering disease that can be complicated by autoimmune disorders. We describe a patient with BP who developed membranous glomerulonephropathy (MN). Proteinuria decreased during the clinical course as anti-BP180 antibody titers decreased. This finding suggested an association between the pathogenesis of these two diseases in terms of immunological disorders.

Entities:  

Keywords:  Autoimmune skin disease; Nephrotic syndrome

Year:  2016        PMID: 28509127      PMCID: PMC5438807          DOI: 10.1007/s13730-016-0243-0

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  22 in total

1.  Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies.

Authors:  Cassian Sitaru; Cornelia Dähnrich; Christian Probst; Lars Komorowski; Inga Blöcker; Enno Schmidt; Wolfgang Schlumberger; Christian Rose; Winfried Stöcker; Detlef Zillikens
Journal:  Exp Dermatol       Date:  2007-09       Impact factor: 3.960

2.  Therapeutic effect of mizoribine on bullous pemphigoid associated with membranous nephropathy.

Authors:  Tamihiro Kawakami; Ayumi Fujita; Sayuri Shirai; Kenjiro Kimura; Yoshinao Soma
Journal:  J Am Acad Dermatol       Date:  2009-03       Impact factor: 11.527

3.  Bullous pemphigoid and membranous glomerulonephropathy in a child.

Authors:  N B Esterly; S P Gotoff; S Lolekha; E S Moore; R D Smith; M Medenica; N L Furey
Journal:  J Pediatr       Date:  1973-09       Impact factor: 4.406

4.  Subclass characteristics of IgG autoantibodies in bullous pemphigoid and pemphigus.

Authors:  Y Shirakata; S Shiraishi; K Sayama; Y Miki
Journal:  J Dermatol       Date:  1990-11       Impact factor: 4.005

5.  Bullous pemphigoid and glomerulonephritis. Report of four cases.

Authors:  C A Simon; R K Winkelmann
Journal:  J Am Acad Dermatol       Date:  1986-03       Impact factor: 11.527

6.  BP230- and BP180-specific auto-antibodies in bullous pemphigoid.

Authors:  Sybille Thoma-Uszynski; Wolfgang Uter; Susanne Schwietzke; Silke C Hofmann; Thomas Hunziker; Philippe Bernard; Regina Treudler; Christos C Zouboulis; Gerold Schuler; Luca Borradori; Michael Hertl
Journal:  J Invest Dermatol       Date:  2004-06       Impact factor: 8.551

7.  Role of BP180NC16a-enzyme-linked immunosorbent assay (ELISA) in the diagnosis of bullous pemphigoid in China.

Authors:  Suying Feng; Lin Lin; Peiying Jin; Qinxue Wu; Wuqing Zhou; Honggui Sang; Changgeng Shao
Journal:  Int J Dermatol       Date:  2008-01       Impact factor: 2.736

8.  Podocytes use FcRn to clear IgG from the glomerular basement membrane.

Authors:  Shreeram Akilesh; Tobias B Huber; Hui Wu; Gary Wang; Björn Hartleben; Jeffrey B Kopp; Jeffrey H Miner; Derry C Roopenian; Emil R Unanue; Andrey S Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-15       Impact factor: 11.205

Review 9.  Bullous pemphigoid-associated nephropathy: report of two cases and review of the literature.

Authors:  E A Ross; A R Ahmed
Journal:  Am J Kidney Dis       Date:  1989-09       Impact factor: 8.860

Review 10.  IgG subclasses and allotypes: from structure to effector functions.

Authors:  Gestur Vidarsson; Gillian Dekkers; Theo Rispens
Journal:  Front Immunol       Date:  2014-10-20       Impact factor: 7.561

View more
  2 in total

1.  Nephrology pictures: pemphigus vulgaris and membranous nephropathy.

Authors:  Gisele Vajgel; Matheus R B Correia; Camila L C Costa; Luis H Sette
Journal:  J Nephrol       Date:  2021-10-15       Impact factor: 3.902

2.  Bullous Pemphigoid: A Spontaneous Presentation in a Patient With Chronic Kidney Disease.

Authors:  Brett Brazen; Ariel Kidron; Zakaria Sheikh; Vikeerna Kamatgi; Sann Htoo
Journal:  Cureus       Date:  2022-06-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.